TickerTry: NVDA · AAPL · PLTR · NFLX
NASDAQ · Healthcare · Biotechnology

Protagonist Therapeutics, Inc.

PTGX

Protagonist Therapeutics, Inc. CEO Dinesh V. Patel · Market cap $6.3B.

$98.54
-1.41 · -1.41%
52w hi $107.8452w lo $43.20
Off 52w high 7.3%
48
ROUTINE
Current InsiderScore
Corp · 90d
8
0 buys · 8 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
Strong Buy
Avg PT $115.40
Section 01

Recent Form 4 filings

16 filings on file
DateInsiderRoleActionSharesPriceValueScore
May 12PATEL DINESH V PH DPresident and CEOSell75,000$100.12−$7.51M48
May 07Bryan GiraudoSell12,000$100.07−$1.20M35
May 07Bryan GiraudoSell36,000$100.14−$3.61M35
Mar 26Harold E SelickSell24,000$105.00−$2.52M32
Mar 26Asif AliChief Financial OfficerSell24,765$104.24−$2.58M38
Mar 26Arturo Molina MDChief Medical OfficerSell15,000$104.79−$1.57M30
Mar 25PATEL DINESH V PH DPresident and CEOSell54,641$101.00−$5.52M37
Feb 17Lewis T WilliamsSell18,000$82.42−$1.48M35
Feb 06William D. WaddillSell20,000$83.68−$1.67M35
Jan 27Asif AliChief Financial OfficerSell28,000$83.13−$2.33M38
Jan 27Asif AliChief Financial OfficerSell18,203$83.14−$1.51M34
Jan 26PATEL DINESH V PH DPresident and CEOSell14,205$84.05−$1.19M31
Jan 23PATEL DINESH V PH DPresident and CEOSell19,315$84.59−$1.63M31
Jan 23Arturo Molina MDChief Medical OfficerSell13,151$82.42−$1.08M30
Jan 20PATEL DINESH V PH DPresident and CEOSell34,438$82.48−$2.84M34
Jul 22PATEL DINESH V PH DPresident and CEOSell22,065$55.05−$1.21M31
Section 02

Recent STOCK Act disclosures

No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03

InsiderScore history

Rolling 12 months · peak score per month
75 · STRONG60 · NOTABLE40 · ROUTINE
JunJulAugSepOctNovDecJanFebMarAprMay
/to search